Hepatocellular Carcinoma in HIV-infected Patients (GEHEP-002)

Hospital Universitario de Valme

Status: Completed

Conditions: Hepatitis B Virus; Liver Cirrhosis; HIV; Hepatocellular Carcinoma; Chronic Hepatitis C

Study type: Observational

Funder types: Other

Identifiers

NCT02785835

GEHEP-002

RIS-VAC12 (Other Identifier)

Details and patient eligibility

About

Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.

Enrollment: 477 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HIV infection
• Diagnosis of hepatocellular carcinoma according to American Association for the Study of Liver Diseases (AASLD) criteria

Exclusion criteria

• None